Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 205583
Company: SUN PHARM
Company: SUN PHARM
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DESVENLAFAXINE | DESVENLAFAXINE FUMARATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL | Discontinued | None | Yes | No |
DESVENLAFAXINE | DESVENLAFAXINE FUMARATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/28/2014 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205583s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205583Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205583Orig1s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205583Orig1s000SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
08/18/2023 | SUPPL-14 | Labeling-Medication Guide, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205583s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/205583Orig1s014ltr.pdf | |
12/10/2019 | SUPPL-10 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205583s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/205583Orig1s010ltr.pdf | |
12/19/2017 | SUPPL-6 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205583s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205583Orig1s006ltr.pdf | |
01/04/2017 | SUPPL-5 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205583s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205583Orig1s005ltr.pdf | |
02/03/2015 | SUPPL-4 | Manufacturing (CMC) |
Label is not available on this site. |
||
07/18/2014 | SUPPL-3 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205583s001s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205583Orig1s001,s003ltr.pdf | |
07/18/2014 | SUPPL-1 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205583s001s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205583Orig1s001,s003ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
08/18/2023 | SUPPL-14 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205583s014lbl.pdf | |
08/18/2023 | SUPPL-14 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205583s014lbl.pdf | |
12/10/2019 | SUPPL-10 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205583s010lbl.pdf | |
12/19/2017 | SUPPL-6 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205583s006lbl.pdf | |
01/04/2017 | SUPPL-5 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205583s005lbl.pdf | |
07/18/2014 | SUPPL-3 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205583s001s003lbl.pdf | |
07/18/2014 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205583s001s003lbl.pdf | |
01/28/2014 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205583s000lbl.pdf |